Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIOCIGUAT vs RISDIPLAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIOCIGUAT vs RISDIPLAM: Safety Overview

Metric RIOCIGUAT RISDIPLAM
Total FAERS Reports 18,268 3,619
Deaths Reported 5,380 336
Death Rate 29.5% 9.3%
Hospitalizations 7,951 719
Average Patient Age 63.9 yrs 21.8 yrs
% Female Patients 70.6% 55.2%
FDA Approval Date Oct 8, 2013 Aug 7, 2020
Manufacturer Bayer HealthCare Pharmaceuticals Inc. Genentech, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription